Heart Disease News and Research

Latest Heart Disease News and Research

Azilsartan medoxomil-CLD phase 3 study results in systolic blood pressure presented at ASH 2011

Takeda Global Research & Development Center, Inc. U.S., today announced results from three phase 3 studies of the investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone.

24 May 2011

Circulation journal introduces new series on preventive cardiology, lifestyle interventions

Today, Circulation: Journal of the American Heart Association launches a year-long themed series that will focus on the prevention of cardiovascular disease.

24 May 2011

Ford engineers develop car seat that can monitor driver's heartbeat

Ford engineers have developed a car seat that can monitor a driver's heartbeat, opening the door to a wealth of health, convenience and even life-saving potential.

24 May 2011

New device can combat hypothermia in wounded soldiers

A Biomedical Engineering Senior Design team at Stevens Institute of Technology is working with the U.S. Army and New Jersey physicians to develop a new device to combat hypothermia among wounded soldiers.

24 May 2011

Future nurses receive NINR grant for cardiovascular disease management research

Future nurse researchers now have more opportunities in the field of cardiovascular risk reduction and disease management research at the Johns Hopkins School of Nursing.

24 May 2011

Researchers discover protein switch that can trigger heart failure

Researchers at the Peter Munk Cardiac Centre discovered a protein switch which can trigger a cascade of events leading to heart failure, pointing to a new direction for drug development.

24 May 2011

TZ Medical, Cinterion announce Aera-CT mHealth heart arrhythmia monitoring device

Cinterion, the global leader in cellular machine-to-machine communication modules and a Gemalto company, and TZ Medical, a leading manufacturer of critical-care medical products, today announced Aera-CT, a lightweight and cost effective mHealth heart arrhythmia monitoring device.

24 May 2011

Altor receives NHLBI SBIR grant to complete ALT-836 second Phase 2 trial in ALI/ARDS

Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.

24 May 2011

'Survival protein' protects brain against effects of stroke

Johns Hopkins scientists say that a newly discovered "survival protein" protects the brain against the effects of stroke in rodent brain tissue by interfering with a particular kind of cell death that's also implicated in complications from diabetes and heart attack.

24 May 2011

Terminally ill missing out on palliative care: Survey reports

According to two new surveys, increased hospital admissions in the last three months of life could be of little benefit to dying people and are in contrast to the wishes of many.

23 May 2011

Discovery of possible new strategy for treating neurologic disorders

23 May 2011

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).

23 May 2011

Elixir DESyne Drug Eluting Coronary Stent System granted CE Mark approval

Elixir Medical Corporation, a developer of product platforms combining state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE Mark for its DESyne Drug Eluting Coronary Stent System for the treatment of coronary artery disease.

23 May 2011

Lifestyle modifications help control blood pressure levels: More evidence

Evidence continues to build that lifestyle modifications help control blood pressure (BP) levels. Data evaluating the consumption of coffee and alcohol and the impact of low fitness levels will be presented at the American Society of Hypertension, Inc.'s 26th Annual Scientific Meeting and Exposition (ASH 2011) and will be featured in the May 22 ASH press briefing.

23 May 2011

Baby boomers becoming the replacement generation

The Associated Press reports that knee and hip replacement surgeries are on the rise for the baby boomer generation, not because of obesity, but because of their efforts to stay fit.

23 May 2011

New hybrid OR at Loyola equipped with advanced fluoroscopy equipment

Loyola University Medical Center has opened a hybrid operating room that combines the imaging capabilities of a cardiac catheterization lab with the sterile environment of a conventional operating room (OR).

23 May 2011

First Edition: May 23, 2011

Today's headlines include reports about a new poll that shows Americans don't believe Medicare has to be cut in order to balance the budget.

23 May 2011

Lund University researcher discovers new sepsis biomarker in blood

Sepsis is the name of an infection that causes a series of reactions in the body, which in the worst case can prove fatal. The problem for both patients and doctors is that the early symptoms are difficult to distinguish from less dangerous infections such as a severe flu or winter vomiting disease.

23 May 2011

New data from ProSavin Phase I/II trial in Parkinson's presented at ASGCT annual meeting

Oxford BioMedica, a leading gene therapy company, announces that new data from the on-going Phase I/II trial of ProSavin for the treatment of Parkinson's disease were presented at the American Society of Gene & Cell Therapy 14th Annual Meeting held in Seattle, USA by Professor Stephane Palfi, Principal Investigator at the Henri Mondor Hospital in Paris, on Saturday 21 May 2011.

23 May 2011

CT scan may help determine early death in individuals with diabetes

New findings out of Wake Forest Baptist Medical Center reveal that a common test may be useful in predicting early death in individuals with diabetes.

23 May 2011